BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND NCOR2, SMRTE-tau, 9612, ENSG00000196498, SMRTE, TNRC14, TRAC-1, SMRT, CTG26, TRAC1 AND Treatment
7 results:

  • 1. germline genetic biomarkers to stratify patients for personalized radiation treatment.
    Deichaite I; Hopper A; Krockenberger L; Sears TJ; Sutton L; Ray X; Sharabi A; Navon A; Sanghvi P; Carter H; Moiseenko V
    J Transl Med; 2022 Aug; 20(1):360. PubMed ID: 35962345
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic analyses of high-grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities.
    Mahdi H; Joehlin-Price A; Elishaev E; Dowlati A; Abbas A
    Mol Oncol; 2021 Dec; 15(12):3545-3558. PubMed ID: 34245124
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1.
    Gallitto M; Cheng He R; Inocencio JF; Wang H; Zhang Y; Deikus G; Wasserman I; Strahl M; Smith M; Sebra R; Yong RL
    J Neurooncol; 2020 May; 147(3):557-566. PubMed ID: 32193690
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Size-based classification of choroidal melanoma and its role in treatment decision-making].
    Brovkina AF; Stoyukhina AS; Chesalin IP
    Vestn Oftalmol; 2016; 132(2):4-7. PubMed ID: 27213790
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. microRNA-100 targets smrt/ncor2, reduces proliferation, and improves survival in glioblastoma animal models.
    Alrfaei BM; Vemuganti R; Kuo JS
    PLoS One; 2013; 8(11):e80865. PubMed ID: 24244722
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2.
    Foley NH; Bray I; Watters KM; Das S; Bryan K; Bernas T; Prehn JH; Stallings RL
    Cell Death Differ; 2011 Jul; 18(7):1089-98. PubMed ID: 21212796
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.
    Ulasov IV; Nandi S; Dey M; Sonabend AM; Lesniak MS
    Mol Med; 2011; 17(1-2):103-12. PubMed ID: 20957337
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.